These Little Companies are Putty in the FDA’s Hands
Jan 15th, 2008 | By Greg Guenthner | Category: Investing Strategies
I was watching a morning financial show the other day that featured an interview with Richard A. Miller, president and CEO of Pharmacyclics, Inc. (Nasdaq: PCYC). Miller was asked on the show to discuss the role the Food and Drug Administration plays in the drug approval process. Just a day ...read more
